These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 37715047)
1. Preventing controlled substance diversion in perioperative settings: a narrative review. Wong MJ; Wang Y; Blake L; Ke JXC Can J Anaesth; 2023 Dec; 70(12):1989-2001. PubMed ID: 37715047 [TBL] [Abstract][Full Text] [Related]
2. Prevention of drug diversion and substance use disorders among anesthesiologists: a narrative review. Fitzsimons MG; de Sousa GS; Galstyan A; Quintão VC; Simões CM Braz J Anesthesiol; 2023; 73(6):810-818. PubMed ID: 37517585 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
5. An Automated Software Application Reduces Controlled Substance Discrepancies in Perioperative Areas. Shah N; Sinha A; Thompson A; Tremper K; Meka A; Kheterpal S Anesthesiology; 2019 Dec; 131(6):1264-1275. PubMed ID: 31730551 [TBL] [Abstract][Full Text] [Related]
6. National Hospital and Health-System Controlled Substances Drug Diversion Prevention & Surveillance Program Assessment Survey - 2021. Fortier CR Am J Health Syst Pharm; 2024 Feb; 81(4):137-145. PubMed ID: 37756623 [TBL] [Abstract][Full Text] [Related]
7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [TBL] [Abstract][Full Text] [Related]
8. Study to assess the impact of analytics software on operating room controlled substance management and drug diversion. Carollo DS; Mullet AP; Hays AJ; Fitzgibbons SA; Nelkin HD; Raymond AP Am J Health Syst Pharm; 2024 May; 81(11):e322-e328. PubMed ID: 38456350 [TBL] [Abstract][Full Text] [Related]
9. The impact of knowledge on attitudes of emergency department staff towards patients with substance related presentations: a quantitative systematic review protocol. Clarke DE; Gonzalez M; Pereira A; Boyce-Gaudreau K; Waldman C; Demczuk L JBI Database System Rev Implement Rep; 2015 Oct; 13(10):133-45. PubMed ID: 26571289 [TBL] [Abstract][Full Text] [Related]
10. New DEA rules expand options for controlled substance disposal. Peterson DM J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):22-6. PubMed ID: 25607591 [TBL] [Abstract][Full Text] [Related]
11. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions. Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350 [TBL] [Abstract][Full Text] [Related]
12. Non-opioid anesthetic drug abuse among anesthesia care providers: a narrative review. Zuleta-Alarcón A; Coffman JC; Soghomonyan S; Papadimos TJ; Bergese SD; Moran KR Can J Anaesth; 2017 Feb; 64(2):169-184. PubMed ID: 27470230 [TBL] [Abstract][Full Text] [Related]
13. Centralizing a controlled substance compliance and drug diversion prevention program within a multihospital health system. Neal D; Mitchell L; Mieure K Am J Health Syst Pharm; 2023 Jul; 80(15):1018-1025. PubMed ID: 37137529 [TBL] [Abstract][Full Text] [Related]
14. Diversion of Controlled Drugs in Hospitals: A Scoping Review of Contributors and Safeguards. Fan M; Tscheng D; Hamilton M; Hyland B; Reding R; Trbovich P J Hosp Med; 2019 Jul; 14(7):419-428. PubMed ID: 31251158 [TBL] [Abstract][Full Text] [Related]
15. Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention. Berge KH; Dillon KR; Sikkink KM; Taylor TK; Lanier WL Mayo Clin Proc; 2012 Jul; 87(7):674-82. PubMed ID: 22766087 [TBL] [Abstract][Full Text] [Related]
16. Controlled substance diversion in health systems: A failure modes and effects analysis for prevention. Nolan K; Zullo AR; Bosco E; Marchese C; Berard-Collins C Am J Health Syst Pharm; 2019 Jul; 76(15):1158-1164. PubMed ID: 31408513 [TBL] [Abstract][Full Text] [Related]
17. Risks of controlled substance drug diversion. Ash TK; Murray G; Hiler RV Am J Health Syst Pharm; 2021 Jun; 78(12):1035-1036. PubMed ID: 33580646 [No Abstract] [Full Text] [Related]
18. ASHP Guidelines on Preventing Diversion of Controlled Substances. Brummond PW; Chen DF; Churchill WW; Clark JS; Dillon KR; Dumitru D; Eschenbacher L; Fera T; Fortier CR; Gullickson KK; Jurakovich K; Kent S; Keonavong J; Marchese C; Meyer T; Murdaugh LB; Ogden RK; O'Neal BC; Rough S; Saenz R; Smith JS Am J Health Syst Pharm; 2017 Mar; 74(5):325-348. PubMed ID: 28052859 [No Abstract] [Full Text] [Related]
19. Prescription drug diversion among substance-impaired pharmacists. Merlo LJ; Cummings SM; Cottler LB Am J Addict; 2014; 23(2):123-8. PubMed ID: 25187048 [TBL] [Abstract][Full Text] [Related]